SCHEMBL25534261

SCHEMBL25534261

CC1(C)c2ccccc2-c2c(-c3ccc(-c4nc(-c5ccccc5)cc(-c5ccccc5-c5ccccc5)n4)c4ccccc34)cccc21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACACA Q13085 1/20 0.34
MEN1 O00255 9/20 0.34
KMT2A Q03164 9/20 0.34
MAPT P10636 7/20 0.34
LMNA P02545 5/20 0.34
SMN1; SMN2 Q16637 4/20 0.34
TDP1 Q9NUW8 2/20 0.34
CYP1A2 P05177 2/20 0.34
CYP2C9 P11712 2/20 0.34
CYP2C19 P33261 2/20 0.34
MAPK10 P53779 1/20 0.34
HPGD P15428 5/20 0.33
ALDH1A1 P00352 5/20 0.33
KDM4E B2RXH2 3/20 0.33
SQOR Q9Y6N5 2/20 0.33
TSHR P16473 1/20 0.33
ATM Q13315 1/20 0.33
NPSR1 Q6W5P4 2/20 0.32
CYP3A4 P08684 1/20 0.32
GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25534240 0.95 MEN1 (0.37) ACACAMEN1KMT2AMAPTLMNA
SCHEMBL25540783 0.94 MEN1 (0.36) ACACAMEN1KMT2AMAPTLMNA
SCHEMBL25534258 0.93 MEN1 (0.36) ACACAMEN1KMT2AMAPTLMNA
SCHEMBL25534252 0.92 MEN1 (0.36) MEN1KMT2AMAPTLMNASMN1; SMN2
SCHEMBL25534055 0.92 MEN1 (0.36) MEN1KMT2AMAPTLMNASMN1; SMN2
SCHEMBL25534059 0.92 MAOB (0.34) MEN1KMT2AMAPTLMNASMN1; SMN2
SCHEMBL25534294 0.91 ENPP1 (0.41) ACACAMAPTSMN1; SMN2TDP1CYP2C9
SCHEMBL25534264 0.91 MEN1 (0.36) ACACAMEN1KMT2AMAPTLMNA
SCHEMBL25534256 0.91 MEN1 (0.36) ACACAMEN1KMT2AMAPTLMNA
SCHEMBL25534060 0.90 MEN1 (0.39) MEN1KMT2AMAPTLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, L1CAM ACACA 1790/4885MEN1 267/4885KMT2A 1094/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.